# Prophylactic Ivermectin in COVID-19 Contacts

> **NCT04422561** · PHASE2,PHASE3 · COMPLETED · sponsor: **Zagazig University** · enrollment: 340 (actual)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Ivermectin Tablets

## Key facts

- **NCT ID:** NCT04422561
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-31
- **Primary completion:** 2020-07-14
- **Final completion:** 2020-07-27
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2020-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04422561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04422561, "Prophylactic Ivermectin in COVID-19 Contacts". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04422561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*